financetom
Business
financetom
/
Business
/
RTX boosts 2024 forecasts again on demand for aircraft repairs, defense systems
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RTX boosts 2024 forecasts again on demand for aircraft repairs, defense systems
Oct 22, 2024 12:07 PM

(Reuters) - RTX on Tuesday raised its 2024 adjusted profit and sales forecasts for the second time, citing strong demand for aircraft repairs and defense systems.

The aerospace and defense giant expects full-year adjusted profit per share to be between $5.50 and $5.58, compared with its prior forecast range of $5.35 to $5.45.

The company raised its revenue forecast range to $79.25 billion to $79.75 billion, from $78.75 to $79.5 billion.

With a surge in air travel demand, airlines had to extend the service life of aircraft amid the limited availability of new commercial planes, creating a bustling aftermarket business.

RTX reported a quarterly per-share profit of $1.45, compared with $1.25 a year earlier. Adjusted sales rose 6% to $20.1 billion.

RTX unit Pratt & Whitney, which competes with CFM International to supply jet engines for Airbus' A320neo family of aircraft, posted a third-quarter operating profit $557 million, compared to a year-ago loss, on demand for repairs.

The business is navigating an ongoing inspection drive to check for flawed components in its geared turbofan (GTF) jet engines that has led to grounding for hundreds of aircraft in recent months.

RTX's Collins Aerospace business, which provides defense products such as test and training range systems and crew escape systems, posted an 18% rise in operating profit to $1.06 billion.

Collins also cited strong demand for aircraft component repairs in the quarter through September.

RTX's other main business, Raytheon, one of the United States government's biggest defense contractors, also reported a higher profit, citing demand for products such as Patriot missile-defense systems.

Tensions in the Middle East and the South China sea, as well as the Ukraine war, have prompted investors pile money into shares of defense majors such as RTX and Lockheed Martin ( LMT ) on anticipation of higher demand for weapons.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MOVES-Goldman Sachs' Spain and Portugal co-head Alvaro del Castano to retire after 30 years
MOVES-Goldman Sachs' Spain and Portugal co-head Alvaro del Castano to retire after 30 years
Oct 8, 2025
Oct 8 (Reuters) - Goldman Sachs Group ( GS ) said in an internal memo seen by Reuters that Alvaro del Castano, its co-head for Spain and Portugal and in charge of private wealth management in the region, will retire after more than three decades at the bank. He is leaving the bank after writing opinion pieces critical of U.S....
Metal coating services firm AZZ Q2 adjusted EBITDA misses estimates
Metal coating services firm AZZ Q2 adjusted EBITDA misses estimates
Oct 8, 2025
Overview * AZZ Inc ( AZZ ) fiscal Q2 sales rise 2% yr/yr to $417.3 mln * Adjusted EPS for fiscal Q2 of $1.55 * Adjusted EBITDA for fiscal Q2 misses analyst expectations Outlook * AZZ maintains FY2026 sales guidance at $1.625 - $1.725 bln * Company expects FY2026 adjusted EBITDA of $360 - $400 mln * AZZ projects FY2026...
Zenta Group Company Limited Announces Full Exercise of Over-Allotment Option
Zenta Group Company Limited Announces Full Exercise of Over-Allotment Option
Oct 8, 2025
MACAU, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Zenta Group Company Limited ( ZGM ) (“Zenta Group” or the “Company”), a Macau-based professional services provider that offers consultation services to industrial park, business investment and sales of fintech products and services, today announced that the underwriters of its previously announced initial public offering (the “Offering”) have exercised their over-allotment option (the...
US FDA expands use of Regeneron's Libtayo as add-on treatment for skin cancer
US FDA expands use of Regeneron's Libtayo as add-on treatment for skin cancer
Oct 8, 2025
Oct 8 (Reuters) - The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals' ( REGN ) immunotherapy, Libtayo, as an add-on treatment for skin cancer patients at high risk of their disease returning after surgery and radiation, the drugmaker said. Libtayo is already approved in the U.S. for advanced skin cancer, basal cell carcinoma, advanced non-small cell lung...
Copyright 2023-2026 - www.financetom.com All Rights Reserved